Editas Medicine (EDIT) executive compensation, 2026 proxy

Gilmore O’Neill, M.B., M.M.Sc., President and Chief Executive Officer, was paid $5.1M in 2025, flat from $5.1M the year before.

Filed
April 28, 2026
Annual meeting
June 17, 2026
Pay year
2025
Named executives
3
CEO total pay
$5.1Mflat vs prior year
CEO pay in equity
32%$1.7M in awards
CEO Salary
$686,574Annual base salary
Option Awards
$1,282,937Grant date fair value
Incentive Plan
$375,164Bonus compensation

How M.M.Sc. was paid

$5.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Named executive officers

ExecutiveTotal
Gilmore O’Neill, M.B., M.M.Sc.President and Chief Executive Officer$5,126,868
Linda C. Burkly, Ph.D.Executive Vice President and Chief Scientific Officer$1,176,389
Amy ParisonSenior Vice President and Chief Financial Officer$821,655

What changed and why

  • $2.4MChief executive officer total compensation for the fiscal year was $2,353,655.
  • $687KSalary for the chief executive officer was $686,574 during the year.
  • $1.3MOption awards for the chief executive officer were valued at $1,282,937.
  • $375KNon-equity incentive plan compensation for the chief executive officer was $375,164.
  • $8,980All other compensation for the chief executive officer totaled $8,980.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.